Bellevue Life Sciences Acquisition - Units (1 Ord, 1 War & 1 Right ) OverviewBellevue Life Sciences Acquisition - Units (1 Ord, 1 War & 1 Right ) EBIT
EBIT (Earnings Before Interest and Taxes) analysis for BLACU.
Quarterly EBIT
-$3.67M
↓ 25.67% YoY
As of Mar 31, 2026
Annual EBIT (TTM)
-$22.89M
↓ 255.84% YoY
Trailing 12 months ending Mar 31, 2026